Vertex Pharmaceuticals (VRTX) Non Operating Investment Income (2009 - 2013)

Vertex Pharmaceuticals' Non Operating Investment Income history runs 4 years deep, the most recent figure standing at $53.5 million for Q4 2013.

• In Q4 2013, Non Operating Investment Income changed N/A year-over-year to $53.5 million; the TTM figure through Dec 2013 stood at $49.9 million (changed N/A YoY), while the FY2013 annual figure was $53.5 million, changed N/A from the prior year.
• Non Operating Investment Income was $53.5 million for Q4 2013 at Vertex Pharmaceuticals, up from -$4.7 million in the prior quarter.
• In the past five years, Non Operating Investment Income ranged from a high of $53.5 million in Q4 2013 to a low of -$27.2 million in Q2 2010.
• Historically, Non Operating Investment Income has averaged -$643166.7 across 4 years, with a median of -$3.3 million in 2009.
• Biggest YoY gain for Non Operating Investment Income was 86.84% in 2011; the steepest drop was 275.96% in 2011.
• A 4-year view of Non Operating Investment Income shows it stood at -$1.8 million in 2009, then slumped by 257.07% to -$6.6 million in 2010, then jumped by 86.84% to -$868000.0 in 2011, then surged by 6260.37% to $53.5 million in 2013.
• The last three Non Operating Investment Income figures came in at $53.5 million (Q4 2013), -$4.7 million (Q3 2013), and $27000.0 (Q2 2013), per Business Quant data.